The Pentobarbital experiment has moved to Propofol and now to Phenobarbital, once again thanks to a pharmaceutical laboratory, and better still a European one!
In its desperate killing quest, the state of Arkansas, where no one has been executed since 2005 and where 38 men await their death, purchased $20,000 worth of Phenobarbital via West-Ward Pharmaceuticals, a subsidiary of Hikma plc whose headquarters are based in London.
As it so happens, Hikma General Assembly will take place tomorrow, May 16th, at 16 Hanover Square in London.
While Hikma says its products cover key therapeutic areas focused on the patient, this newly found death market is becoming another key in its commercial strategies.
Tell Hana Ramadan at email@example.com, Corporate Communication Director of Hikma the killing lab, how you feel about their choices and ask whether their shareholders are aware of the situation. No direct contact information seems available to contact the shareholders, so let’s share this via Twitter and Facebook:
#Hikma, the new death lab kills people #Darhold #SectoralAssetManagement
As the state of Arkansas attempts to use Phenobarbital to kill 3 persons in the near future, let’s not forget that the same state ranks nationally #45 in education, #48 in healthcare and #10 in incarceration rate.
State-sanctioned murders must stop now! Europe has a very clear position on the issue of the death penalty and European laboratories would be well advised to respect ethics and life in order to improve their patients’ health.
Please act and share this post NOW!